group (P = 0.029). Overall length of stay was unchanged between the groups (P = 0.873).
Conclusion. Introduction of Alere ® reduced time to appropriate therapy and reduced empiric Gram negative coverage in patients being treated for orthopedic hardware infections.
Disclosures. All authors: No reported disclosures. Background. Fosfomycin (FOS) is a broad-spectrum bactericidal agent that has been suggested as an alternative treatment option for infections caused by multi-drug resistant Gram-negatives. The approved in vitro antimicrobial susceptibility testing method for FOS is agar dilution (AD) and disk diffusion (DD); however, broth microdilution (BMD) is the basis of automated systems used in clinical microbiology laboratories. Herein we evaluated the accuracy of BMD and DD vs. the gold standard AD test for FOS susceptibility assessment using clinical isolates.
Evaluation of Susceptibility Testing Methods for Fosfomycin Against
Methods. Susceptibility to FOS of 140 isolates, comprising 39 E. coli (Eco), 33 K. pneumoniae (Kpn), 9 Enterobacter spp., (Ent); and 59 P. aeruginosa (Pae), were determined by BMD, DD and AD. Mueller-Hinton supplemented with 25 mg/L glucose 6-phosphate (G6P) was used for BMD and AD; results were interpreted according to CLSI and EUCAST guidelines. For DD screening, 50 μg FOS discs supplemented with 50 μg G6P were used and interpretation was performed following the FMS. For Pae, the EUCAST epidemiological cutoff was used. Concordance of BMD and DD with AD is reported in terms of categorical agreement (CA), defined as results between the two methods that matched based on the interpretative breakpoint proposed; false-resistant results to be major errors (ME); and false-susceptible results to be very major errors (VME).
Results. According to AD, the susceptibility to FOS of Eco, Kpn, Ent, and Pae was 97.4, 72.7, 100, and 98.3% respectively. Concordance analysis between BMD and DD with the gold standard AD is shown in Table 1 .
Conclusion. The high proportion of ME found with BMD, which is used in the automated systems may cause an overestimation of the FOS resistance, especially in Kpn and Ent. Thus, we suggest that microbiology laboratories confirm resistant strains by AD. DD may be useful for Eco and Ent, when scattered colonies within inhibition zones are ignored. Results also show high rates of FOS susceptibility among clinical isolates. Background. Cefazolin is becoming first-line therapy for MSSA infections since it appears to be better tolerated than isoxazolyl penicillins with similar outcomes. An important concern when using cephalosporins as first-line therapy for MSSA is the CzIE, defined as MICs ≥ 16 µg/mL when performed at high bacterial inoculum (~10 7 CFU/mL) compared with standard inoculum (~10 5 CFU/mL). We postulated that release of BlaZ (a lipoprotein) to the extracellular milieu is the mechanism responsible for the CzIE. Confirmation of this phenomenon would permit developing a rapid test to identify this phenomenon in clinical settings.
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Methods. We monitored the hydrolysis of 50 μM of nitrocefin by S. aureus supernatants after induction with ampicillin (150 µg/mL) for 1 h. A total of 150 μL of supernatants (after centrifugation) was incubated with 50 μM nitrocefin at 25°C in 20 mM HEPES, pH 7.4, 100 mM NaCl for 30 minutes. Nitrocefin hydrolysis was monitored by following the change in absorbance at 482 resulting from opening of the β-lactam ring of nitrocefin. Visual inspection to monitor color changes was also performed. We initially used 3 strains of MSSA, (i) S. aureus TX0117, a well-characterized strain that exhibits the CzIE; (ii) TX0117c, a derivative of TX0117 that harbors a mutation inactivating BlaZ and abolishing the CzIE, and (iii) ATCC 29213 a BlaZ-positive strain that lacks the CzIE. Subsequently, we validated the methodology in 10 South American isolates of different backgrounds that had been previously characterized for the CZIE.
Results. A statistically significant difference in ODs after 30 minutes was observed in TX0117 (CzIE) vs. TX0117c (no CzIE) and ATCC 29213 (no CzIE) (all P < 0.001), suggesting high BlaZ activity in supernatants of TX0117 and supporting the release of the enzyme as the main mechanism of the CzIE. All South American isolates that exhibited the CzIE were identified by the nitrocefin assay. Of note, isolates producing Type C BlaZ gave a weaker reaction, although still significantly different from isolates without the CzIE. Hydrolysis of nitrocefin was also readily detectable by visual inspection.
Conclusion. The CzIE is likely due to release of BlaZ to the extracellular milieu. A rapid test that can readily identify MSSA strains exhibiting the CzIE is feasible. 
